• Pan American Energy (CSE:PNRG) has revealed assay results from its 2023-2024 diamond drill project at the Big Mack Lithium Project in Ontario
  • The final phase of the drilling program focused on areas of the property outside the known mineralized zones
  • The program also intended to test prospective areas extending along strike and down dip of previously identified mineralization
  • Shares of Pan American Energy are up 3.45 per cent to C$0.15 as of 10:40 am ET

Pan American Energy (CSE:PNRG) has revealed assay results from its 2023-2024 diamond drill project at the Big Mack Lithium Project in Ontario.

In a news release, the Calgary-based company stated the final phase of the drilling program focused on areas of the property outside the known mineralized zones.

The program also intended to test prospective areas extending along strike and down dip of previously identified mineralization.

“Our team has further expanded on the newly identified mineralized zones in areas where high-grade lithium had not previously been identified,” Jason Latkowcer, CEO of Pan American Energy, said in a statement. “This proves to us that additional discoveries can be made at the Property, and as we refine our understanding of the geology, we will look to follow up these intercepts as they remain open at depth and along strike.”

The company said drill targets were identified using the 2023 geochemical surface sampling results and previously collected UAV detailed magnetic survey data.

Certain infill holes within the Eleven zone and Big Mack Pegmatite was also included in the last phase of drilling.

Pan American Energy is an exploration stage company engaged principally in the acquisition, exploration and development of mineral properties containing battery metals in North America.

Shares of Pan American Energy Corp. (CSE:PNRG) are up 3.45 per cent to C$0.15 as of 10:40 am ET

Join the discussion: Find out what everybody’s saying about this stock on the Pan American Energy Corp. Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online

FSD Pharma submits MS treatment clinical trial for review in Australia

FSD Pharma (CSE:HUGE) submits its MS treatment's Phase-1 Multiple Ascending Doses Clinical Trial Application for ethics review in Australia.

Cloud DX signs fourth contract with a provincial health authority

Cloud DX (TSXV:CDX) signs its fourth contract with a provincial health authority for remote patient monitoring.

International Petroleum stock rallies on Q1 results

Canadian energy stock International Petroleum Corp. (TSX:IPCO) rose in Tuesday trading on its Q1 2024 financial...

York Harbour Metals reveals promising rare earth sampling assays

York Harbour Metals (TSXV:YORK) shares positive assays from its Bottom Brook rare earth elements project in Newfoundland and Labrador.